NCT04776304 (ArtTherapy) is a NA clinical trial of Art Therapy in Post-Traumatic Headache, sponsored by Walter Reed National Military Medical Center.

Who is sponsoring NCT04776304?

NCT04776304 is sponsored by Walter Reed National Military Medical Center.

What drugs are being tested in NCT04776304?

Interventions in NCT04776304: Art Therapy.

What condition does NCT04776304 study?

NCT04776304 studies Post-Traumatic Headache, PTSD, TBI, TBI (Traumatic Brain Injury), MTBI - Mild Traumatic Brain Injury, Posttraumatic Stress Disorder, Posttraumatic Stress Disorder, Delayed Onset, Sleep Disturbance, Nightmare, Nightmares, REM-Sleep Type, Headache, Irritable Mood, Anger, Eating Disorders, Combat and Operational Stress Reaction, Combat Stress Disorders, Military Operations, Military Activity, Military Family.

Is NCT04776304 still recruiting?

NCT04776304 is currently completed. Last updated 6 November 2024.

Last reviewed 2024-11-06 · How we verify

NCT04776304: ArtTherapy

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Art Therapy QEEG Study for Service Members with a Traumatic Brain Injury and Posttraumatic Stress Symptoms

Completed NA Last updated 6 November 2024

What this trial tests

NA trial testing Art Therapy in Post-Traumatic Headache in 2 participants. Completed in 25 January 2024.

Timeline

30 October 2021

Primary endpoint
25 January 2024

25 January 2024

Quick facts

Lead sponsor	Walter Reed National Military Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	2
Start date	30 October 2021
Primary completion	25 January 2024
Estimated completion	25 January 2024
Sites	1 location across United States

Drugs / interventions tested

Art Therapy — full drug profile →

Conditions studied

Post-Traumatic Headache — all drugs for Post-Traumatic Headache →
PTSD — all drugs for PTSD →
TBI — all drugs for TBI →
TBI (Traumatic Brain Injury) — all drugs for TBI (Traumatic Brain Injury) →

Sponsor

Walter Reed National Military Medical Center

Who can join

Adults 18 to 64, any sex, with Post-Traumatic Headache or PTSD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Service members and/or recently separated veterans with post traumatic stress symptoms and mild traumatic brain injury may participate in 8 sessions including 2 sessions including interviews and questionnaires as well as 6 sessions of art therapy. In the art therapy, participants will be provided with a blank paper mache mask template and invited to alter the mask however they wish using a variety of art materials. The therapist will use the art-making process and culminating product to aid in self-reflection, reframe negative thoughts and feelings, and work through traumatic content. Prior to the session start participants will get set up with a mobile qEEG (worn like a hat and backpack). The qEEG will measure brain activity in a non-invasive way throughout the art therapy session to improve understanding of brain activity during the art therapy process.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Art Therapy

Trials testing the same drug.

NCT07162428 — The Effect of Art Therapy on Disease Severity and Anxiety Levels in Inpatients at a Psychiatry Clinic · NA · not yet recruiting
NCT06945497 — School-based Practices in Arts and Resilience for Kids · NA · not yet recruiting
NCT07097675 — The Change in Psychoemotional State of Individuals With Dementia Syndrome Applying Art Therapy · NA · not yet recruiting
NCT07089927 — Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Sur · NA · recruiting
NCT06342453 — CREATE: Art for Children With Cancer · NA · recruiting

Other Walter Reed National Military Medical Center trials

Trials by the same sponsor.

NCT07151417 — Use of Corticosteroid in Intraopertive Injections in Total Knee Replacement Surgery. · Phase 2, PHASE3 · not yet recruiting
NCT06636136 — Transtibial Osseointegration · NA · recruiting
NCT06808347 — Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Pos · Phase 4 · not yet recruiting
NCT06731348 — Patient Satisfaction With Opioid Restriction After Urogynecologic Surgery · Phase 4 · enrolling by invitation
NCT06729151 — Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patient · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04776304 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Walter Reed National Military Medical Center
Last refreshed: 6 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04776304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing